Endocrine Oncology
Tumor risks and surveillance outcomes in SDHA variant carriers

Cohort study of 106 peoplePopulations
Declared no competing interests
- Tumor screening
- Gastrointestinal stromal tumor
- Hereditary cancer-predisposing syndrome
- Paraganglioma
- Paraganglioma-pheochromocytoma
- Humans
The paper
Huntsman Cancer Institute; University of Utah
Endocrine Oncology, 11 Sep 2026